Teradyne, Inc. Work in process increased by 17.0% to $56.01M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.5%, from $50.68M to $56.01M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 13.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.88M | $34.91M | $37.74M | $30.88M | $36.18M | $42.09M | $37.98M | $43.99M | $43.69M | $40.13M | $26.85M | $39.87M | $43.49M | $48.25M | $41.96M | $50.68M | $51.14M | $57.05M | $47.88M | $56.01M |
| QoQ Change | — | -7.8% | +8.1% | -18.2% | +17.2% | +16.3% | -9.8% | +15.8% | -0.7% | -8.1% | -33.1% | +48.5% | +9.1% | +10.9% | -13.0% | +20.8% | +0.9% | +11.6% | -16.1% | +17.0% |
| YoY Change | — | — | — | — | -4.5% | +20.6% | +0.6% | +42.5% | +20.7% | -4.7% | -29.3% | -9.4% | -0.4% | +20.2% | +56.3% | +27.1% | +17.6% | +18.2% | +14.1% | +10.5% |
| % of Inventories | 16.8% | 15.6% | 15.5% | 11.9% | 12.2% | 13.5% | 11.7% | 12.5% | 12.6% | 12.4% | 8.7% | 12.7% | 15.1% | 16.2% | 14.1% | 14.7% | 14.6% | 15.6% | 12.6% | 15.4% |
| Share Change | — | -1.2pp | -0.1pp | -3.6pp | +0.3pp | +1.3pp | -1.9pp | +0.8pp | +0.1pp | -0.1pp | -3.8pp | +4.0pp | +2.4pp | +1.2pp | -2.2pp | +0.6pp | -0.1pp | +1.0pp | -2.9pp | +2.8pp |